black box warning for glp 1 agonists The popularity of GLP-1 weight loss drugs is bringing back a historic affliction…scurvy. DETAILS: https://fox8.com/news/glp-1 -drugs-may-cause-scurvy-in-patients-reports Exploring the Side Effects of
Description
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: A randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
Kelly and Sipos 2024)
Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists
The advent of oral formulations, including semaglutide and ofrutide, has further enhanced patient adherence
The role of glucagonlike peptide 1 (GLP1) in addictive disorders
